JPS62215581A
(ja)
*
|
1986-03-18 |
1987-09-22 |
Koichi Shiyudo |
フラボンカルボン酸誘導体
|
WO1987007835A1
(en)
*
|
1986-06-21 |
1987-12-30 |
Dainippon Ink And Chemicals, Inc. |
Drug for treatment and prophylaxis of kidney and liver diseases
|
US4808631A
(en)
*
|
1986-11-07 |
1989-02-28 |
Hoffmann-La Roche Inc. |
Aromatic acid derivatives
|
US5264578A
(en)
*
|
1987-03-20 |
1993-11-23 |
Allergan, Inc. |
Disubstituted acetylenes bearing heterobicyclic groups and heteroaromatic or phenyl groups having retinoid like activity
|
US4939156A
(en)
*
|
1987-07-11 |
1990-07-03 |
Meiji Seika Kaisha, Ltd. |
New tetramethyl-cis-diaza-bicyclo{4.2.0}octane-3,5-dione derivatives having differentiation-inducing activity and antiviral activity
|
LU87039A1
(fr)
*
|
1987-11-04 |
1989-06-14 |
Oreal |
Esters biaromatiques d'antibiotiques macrolidiques et lincosamidiques,leur procede de preparation et compositions pharmaceutiques et cosmetiques les contenant
|
LU87037A1
(fr)
*
|
1987-11-04 |
1989-06-14 |
Oreal |
Esters polyaromatiques d'antibiotiques macrolidiques et lincosamidiques,leur procede de preparation et compositions pharmaceutiques et cosmetiques les contenant
|
JP2752630B2
(ja)
*
|
1988-03-29 |
1998-05-18 |
大鵬薬品工業株式会社 |
新規安息香酸誘導体及びその製造方法
|
KR0139216B1
(ko)
*
|
1988-04-11 |
1998-05-01 |
제임스 엠. 캐내지 |
레티노이드 유사활성을 갖는 페놀 또는 벤조산의 테트랄린 에스테르
|
DE3830054A1
(de)
*
|
1988-09-03 |
1990-03-15 |
Boehringer Mannheim Gmbh |
Phenylamide - verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel
|
US5527945A
(en)
*
|
1989-02-10 |
1996-06-18 |
Basf Aktiengesellschaft |
Diphenylheteroalkyl derivatives, the preparation thereof and drugs and cosmetics prepared therefrom
|
DE3903989A1
(de)
*
|
1989-02-10 |
1990-09-20 |
Basf Ag |
Diphenylheteroalkylderivate, ihre herstellung und daraus hergestellte arzneimittel und kosmetika
|
IT1232252B
(it)
*
|
1989-02-22 |
1992-01-28 |
Rotta Research Lab |
Derivati della n fenil benzamide ad attivita' antiulcera ed antiallerica e procedimento per la loro preparazione
|
CA2020887A1
(en)
*
|
1989-07-28 |
1991-01-29 |
Michael Klaus |
Aromatic carboxylic amides
|
US5272156A
(en)
*
|
1989-09-19 |
1993-12-21 |
Allergan, Inc. |
Acetylenes disubstituted with a heteroaromatic group and a 2-substituted 1,2,3,4-tetrahydroquinolinyl group having retinoid-like activity
|
US5183827A
(en)
*
|
1989-09-19 |
1993-02-02 |
Allergan, Inc. |
Acetylenes disubstituted with a heteroaromatic group and a 2-substituted chromanyl, thiochromanyl or 1,2,3,4-tetrahydroquinolinyl group having retinoid-like activity
|
US5264456A
(en)
*
|
1989-12-29 |
1993-11-23 |
Allergan, Inc. |
Acetylenes disubstituted with a furyl group and a substituted phenyl group having retinoid like activity
|
US5668175A
(en)
*
|
1991-08-23 |
1997-09-16 |
The Salk Institute For Biological Studies |
Use of selective ligands for treatment of disease states responsive to steroid or steroid-like retinoids
|
DE69232188T2
(de)
*
|
1991-08-23 |
2002-06-20 |
Ligand Pharmaceuticals, Inc. |
Verwendung von selektiven liganden zur behandlung von hormonansprechenden krankheitzuständen
|
EP0617020A1
(de)
*
|
1992-04-02 |
1994-09-28 |
Shudo, Koichi, Prof. Dr. |
Carbonsäure mit retinsäure-ähnlicher Wirkung
|
US5324840A
(en)
*
|
1992-06-11 |
1994-06-28 |
Allergan, Inc. |
Method of treatment with compounds having retinoid-like activity and reduced skin toxicity and lacking teratogenic effects
|
US5455265A
(en)
|
1993-02-11 |
1995-10-03 |
Allergan, Inc. |
Method of treatment with compounds having selective agonist-like activity on RXR retinoid receptors
|
US6172115B1
(en)
|
1993-02-11 |
2001-01-09 |
Allergan Sales, Inc. |
Method for preventing onset of restenosis after angioplasty employing an RXR-specific retinoid
|
EP0619116A3
(en)
*
|
1993-04-05 |
1994-11-23 |
Hoechst Japan |
Use of synthetic retinoids for osteopathy.
|
US5475022A
(en)
*
|
1993-10-18 |
1995-12-12 |
Allergan, Inc. |
Phenyl or heteroaryl and tetrahydronaphthyl substituted diene compounds having retinoid like biological activity
|
FR2713635B1
(fr)
*
|
1993-12-15 |
1996-01-05 |
Cird Galderma |
Nouveaux composés propynyl bi-aromatiques, compositions pharmaceutiques et cosmétiques les contenant et utilisations.
|
US5426118A
(en)
*
|
1993-12-30 |
1995-06-20 |
Allergan, Inc. |
[4-(1,2-epoxycyclohexanyl)but-3-en-1-ynyl]aromatic and heteroaromatic acids and derivatives having retinoid-like biological activity
|
US5648385A
(en)
*
|
1994-01-03 |
1997-07-15 |
Bristol-Myers Squibb Co. |
Retinoid-like compounds
|
JP2848964B2
(ja)
*
|
1994-08-10 |
1999-01-20 |
エフ・ホフマン−ラ ロシュ アーゲー |
レチノイン酸x受容体リガンド
|
US5498755A
(en)
*
|
1994-08-23 |
1996-03-12 |
Chandraratna; Roshantha A. |
Disubstituted aryl and heteroaryl imines having retinoid-like biological activity
|
US6133326A
(en)
|
1994-08-31 |
2000-10-17 |
Pfizer Inc |
Compositions and methods for decreasing sebum production
|
US5977125A
(en)
|
1994-10-31 |
1999-11-02 |
Eisai Co., Ltd. |
Mono-or polyenic carboxylic acid derivatives
|
US5514825A
(en)
*
|
1994-12-29 |
1996-05-07 |
Allergan, Inc. |
Acetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activity
|
US5543534A
(en)
*
|
1994-12-29 |
1996-08-06 |
Allergan |
Acetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl or heteroaryl groups having retinoid-like biological activity
|
US5489584A
(en)
*
|
1994-12-29 |
1996-02-06 |
Allergan, Inc. |
Acetylenes disubstituted with a 5-amino or substituted 5-amino substituted tetrahydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activity
|
US5599967A
(en)
*
|
1994-12-29 |
1997-02-04 |
Allergan |
Acetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl of heteroaryl group having retinoid-like biological activity
|
US5534641A
(en)
*
|
1994-12-29 |
1996-07-09 |
Allergan |
Acetylenes disubstituted with 2-tetrahydropyranoxyaryl and aryl or heteroaryl groups having retinoid-like biological activity
|
US5556996A
(en)
*
|
1994-12-29 |
1996-09-17 |
Allergan |
Oxiranyls disubstituted with a phenyl group and a substituted chromanyl or tetrahydroquinolinyl group having retinoid like activity
|
US5618931A
(en)
*
|
1994-12-29 |
1997-04-08 |
Allergan |
Acetylenes disubstituted with a 5 substituted dihydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activity
|
US5618943A
(en)
*
|
1994-12-29 |
1997-04-08 |
Allergan |
Acetylenes disubstituted with a 5 OXO substituted tetrahydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activity
|
US5559248A
(en)
*
|
1995-04-05 |
1996-09-24 |
Bristol-Myers Squibb Co. |
Retinoid-like heterocycles
|
US6025388A
(en)
*
|
1995-04-26 |
2000-02-15 |
Allergan Sales, Inc. |
Method for inhibiting gene expression promoted by AP1 protein with RARβ selective retinoids and method for treatment of diseases and conditions with such retinoids
|
US5616712A
(en)
*
|
1995-05-16 |
1997-04-01 |
Allergan |
Acetylenes disubstituted with a phenyl or heteroaryl group and a 2-thio-1,2,3,4-tetrahdroquinolinyl, 2-alkylthio-3,4-dihydroquinolinyl or 2-alkoxy-3,4-dihydroquinolinyl group having retinoid-like biological activity
|
US5675033A
(en)
*
|
1995-06-06 |
1997-10-07 |
Allergan |
2,4-pentadienoic acid derivatives having retinoid-like biological activity
|
JP3964478B2
(ja)
|
1995-06-30 |
2007-08-22 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
ヘテロ環含有カルボン酸誘導体及びそれを含有する医薬
|
AU7598596A
(en)
*
|
1995-11-01 |
1997-05-22 |
Allergan, Inc. |
Sulfides, sulfoxides and sulfones disubstituted with a tetrahydronaphthalenyl, chromanyl, thiochromanyl or tetrahydroquinolinyl and substituted phenyl or heteroaryl group, having retinoid-like biological activity
|
US5726191A
(en)
*
|
1995-11-16 |
1998-03-10 |
Hoffmann-La Roche Inc. |
Aromatic carboxylic acid esters
|
US5675024A
(en)
*
|
1995-11-22 |
1997-10-07 |
Allergan |
Aryl or heteroaryl amides of tetrahydronaphthalene, chroman, thiochroman and 1,2,3,4,-tetrahydroquinoline carboxylic acids, having an electron withdrawing substituent in the aromatic or heteroaromatic moiety, having retinoid-like biological activity
|
US5663357A
(en)
*
|
1995-11-22 |
1997-09-02 |
Allergan |
Substituted heteroarylamides having retinoid-like biological activity
|
US5965606A
(en)
|
1995-12-29 |
1999-10-12 |
Allergan Sales, Inc. |
Methods of treatment with compounds having RAR.sub.α receptor specific or selective activity
|
US5688957A
(en)
*
|
1995-12-29 |
1997-11-18 |
Allergan |
(3"-thioxacyclohex-1"-enyl)!-but-3'-ene-1'-ynyl!aryl and (3"-thioxacyclohex-1"-enyl)!-but-3'-ene-1'-ynyl!heteroaryl carboxylic acids and esters having retinoid-like biological activity
|
US5763635A
(en)
*
|
1996-06-21 |
1998-06-09 |
Allergan |
Tetrahydronaphthalene derivatives substituted in the 8 position with alkyhidene groups having retinoid and/or retinoid antagonist-like biological activity
|
US5741896A
(en)
*
|
1996-06-21 |
1998-04-21 |
Allergan |
O- or S- substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
|
US5747542A
(en)
*
|
1996-06-21 |
1998-05-05 |
Allergan |
Oxo-substituted tetrahydronaphthalene derivatives having retinold and/or retinoid antagonist-like biological activity
|
US5808124A
(en)
*
|
1996-06-21 |
1998-09-15 |
Allergan |
O- or S-substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
|
US5723666A
(en)
*
|
1996-06-21 |
1998-03-03 |
Allergan |
Oxime substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
|
JPH10158192A
(ja)
|
1996-10-03 |
1998-06-16 |
Eisai Co Ltd |
移植片対宿主疾患(gvhd)の治療および臓器移植時の移植片拒絶反応抑制のための医薬組成物
|
US5739338A
(en)
*
|
1996-11-05 |
1998-04-14 |
Allergan |
N-aryl substituted tetrahydroquinolines having retinoid agonist, retinoid antagonist or retinoid inverse agonist type biological activity
|
US5728846A
(en)
*
|
1996-12-12 |
1998-03-17 |
Allergan |
Benzo 1,2-g!-chrom-3-ene and benzo 1,2-g!-thiochrom-3-ene derivatives
|
US5760276A
(en)
*
|
1997-03-06 |
1998-06-02 |
Allergan |
Aryl-and heteroarylcyclohexenyl substituted alkenes having retinoid agonist, antagonist or inverse agonist type biological activity
|
US6037488A
(en)
*
|
1997-04-19 |
2000-03-14 |
Allergan Sales, Inc. |
Trisubstituted phenyl derivatives having retinoid agonist, antagonist or inverse agonist type biological activity
|
US5919970A
(en)
*
|
1997-04-24 |
1999-07-06 |
Allergan Sales, Inc. |
Substituted diaryl or diheteroaryl methanes, ethers and amines having retinoid agonist, antagonist or inverse agonist type biological activity
|
US6008251A
(en)
*
|
1998-03-27 |
1999-12-28 |
Bristol-Myers Squibb Company |
Retinoid-like compounds
|
FR2779720B1
(fr)
|
1998-06-12 |
2002-08-16 |
Galderma Rech Dermatologique |
Nouveaux composes diarylselenures et leur utilisation en medecine humaine ou veterinaire ainsi qu'en cosmetologie
|
US7321050B2
(en)
|
1999-12-06 |
2008-01-22 |
Welichem Biotech Inc. |
Anti-inflammatory and psoriasis treatment and protein kinase inhibition by hydroxy stilbenes and novel stilbene derivatives and analogues
|
US20030171429A1
(en)
*
|
1999-12-06 |
2003-09-11 |
Genhui Chen |
Anti-inflammatory and psoriasis treatment and protein kinase inhibition by hydroxyltilbenes and novel stilbene derivatives and analogues
|
US6313107B1
(en)
|
2000-08-29 |
2001-11-06 |
Allergan Sales, Inc. |
Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI
|
US6387951B1
(en)
|
2000-08-29 |
2002-05-14 |
Allergan Sales, Inc. |
Compounds having activity as inhibitors of cytochrome P450RAI
|
US6369261B1
(en)
|
2000-08-29 |
2002-04-09 |
Allergan Sales, Inc. |
Compounds having activity as inhibitors of cytochrome P450RAI
|
US6380256B1
(en)
|
2000-08-29 |
2002-04-30 |
Allergan Sales, Inc. |
Compounds having activity as inhibitors of cytochrome P450RAI
|
TWI288129B
(en)
|
2000-09-01 |
2007-10-11 |
Toko Pharmaceuticals Ind Co Lt |
Process for the production of crystals of a benzoic acid derivative
|
US20050202055A1
(en)
*
|
2004-03-11 |
2005-09-15 |
Koichi Shudo, Tokyo, Japan |
Anti-wrinkle agent
|
EP1930001A4
(de)
*
|
2005-09-09 |
2010-07-21 |
Kemphys Ltd |
Pharmazeutisches mittel zur prävention und/oder behandlung von darmerkrankungen
|
JP2008081427A
(ja)
*
|
2006-09-27 |
2008-04-10 |
R&R Inc |
分泌障害性疾患の予防及び/又は治療のための医薬
|
CN101200435B
(zh)
*
|
2006-12-12 |
2011-12-07 |
江苏恒瑞医药股份有限公司 |
他米巴罗汀ⅱ型结晶的制备方法
|
US7902260B2
(en)
*
|
2007-02-28 |
2011-03-08 |
Kemphys Ltd. |
Medicament for preventive and/or therapeutic treatment of lower urinary tract symptom
|
GB0915196D0
(en)
|
2009-09-01 |
2009-10-07 |
King S College London |
Therapeutic compounds and their use
|
CN103664680A
(zh)
*
|
2012-09-26 |
2014-03-26 |
山东鲁北药业有限公司 |
一种他米巴罗汀合成的新工艺
|
MX2017012470A
(es)
|
2015-03-31 |
2018-03-23 |
Syros Pharmaceuticals Inc |
Metodos para estratificacion de pacientes para tratamiento con agonistas del receptor alfa de acido retinoico.
|
AU2017248187B2
(en)
|
2016-04-08 |
2023-03-16 |
Syros Pharmaceuticals, Inc. |
Rara agonists for the treatment of AML and MDS
|
US9868994B2
(en)
|
2016-04-08 |
2018-01-16 |
Syros Pharmaceuticals, Inc. |
Methods of stratifying patients for treatment with retinoic acid receptor-α agonists
|
CA3082115A1
(en)
|
2017-11-10 |
2019-05-16 |
Dermavant Sciences GmbH |
Process for preparing tapinarof
|